Navigation Links
MiMedx Plantar Fasciitis Study Published In The Foot & Ankle International Journal
Date:8/20/2013

MARIETTA, Ga., Aug. 20, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its study "Prospective, Randomized, Blinded, Comparative Study of Injectable Micronized Dehydrated Amniotic/Chorionic Membrane Allograft for Plantar Fasciitis—A Feasibility Study" has been electronically published in the journal, Foot & Ankle International. The study publication was authored by Charles M. Zelen, DPM, Attila Poka, MD, and James Andrews, MD. The hard copy is scheduled to be published in the October 2013 edition of Foot & Ankle International. The electronic publication of the study is available at http://fai.sagepub.com/content/early/recent.

The randomized clinical trial examined the efficacy of dehydrated human amnion/chorion membrane (dHACM) injection as a treatment for the inflammation associated with chronic refractory plantar fasciitis. The study determined that this injection for plantar fasciitis can reduce inflammation and promote healing and may be an alternative to surgical intervention. "In summary, this RCT concluded that patients with chronic/refractory plantar fasciitis randomized to receive a single-dose injection of AmnioFix® experienced significant improvement in symptoms and increased function within one week of injection, with continued improvement over the eight-week study period," said Parker H. Petit, Chairman and CEO.

"This is our first randomized control trial (RCT) conducted on our amnion allograft use in plantar fasciitis. This degenerative condition is one of the most common
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MiMedx Group, Inc. to Present at the 6th Annual Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
2. MiMedx Group Completes $5,000,000 Private Placement
3. MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
4. MiMedx to Present at American Academy of Orthopaedic Surgeons Annual Meeting
5. MiMedx Group Announces 2011 Results
6. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
7. MiMedx Exceeds Revenue Goal for First Quarter of 2012
8. MiMedx Group Announces Record First Quarter Results
9. MiMedx Group, Inc. Announces Release Date for 2012 Second Quarter Results
10. MiMedx Group Announces Record Second Quarter Results
11. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/v6klp2/nanobiotechnology ... PharmaBiotech,s new report "Nanobiotechnology Applications, Markets ... An increasing use of nanobiotechnology ... anticipated. Nanotechnology will be applied at all ... for optimal delivery to diagnostic applications in ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... Israel , September 2, 2015 ... the intent of the National Institute of Allergy and Infectious ... (NIH) within the Department of Health and Human Services (HHS), ... in the United States in the ... universal flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... MedPredict Market Research,a global provider of ... a new report providing critical strategic insight,for ... in the market for MS,therapies. In ... & Analysis:,Multiple Sclerosis," physician experts discuss the ...
... Business Update - ... Time -, OAKLAND, Calif., Nov. 14 World Heart,Corporation ... circulatory,support systems, will report its third quarter 2007 financial results ... in a,teleconference at 8:30 a.m. Pacific / 11:30 a.m. Eastern ...
... Following the Screening and the Testing of Hundreds ... Reduce Liver Cancer Cell Growth, REHOVOT, Israel ... Genomics, Ltd. (NASDQ: ROSG) announced,today the initiation of ... program conducted in collaboration with Isis Pharmaceuticals(1),(NASDAQ: ...
Cached Biology Technology:New Report Analyzes Key Controversies in Multiple Sclerosis Treatment 2Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer 2Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer 3Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer 4
(Date:8/11/2015)... Sweden , August 11, 2015 Today, ... FPC1155. Already received as well as expected revenues in 2015 that ... in FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a prominent smartphone manufacturer in ... ZUK selected FPC1 155 for ...
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/5/2015)... , August 5, 2015 ... & Access Management Market by Software, Services, Vertical (BFSI, Airport, ... & Geography - Global Forecast to 2020", published by ... Management Market globally into various segments. The global PIAM ... 2014 to $546.2 Million by 2019, at a CAGR ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... in Madagascar regularly retire to limestone chambers for their ... use of the same caves and crevices for sleeping ... lemurs may be opting to sleep in caves for ... Professor Michelle Sauther, who led the study. While the ...
... 4, 2013 A team of Montral researchers at the ... Dr. William C. Wetsel,s team at Duke University in the ... role in the brain by affecting certain types of cognitive ... recently published in the scientific journals Proceedings of the ...
... 4, 2013 Elsevier, EuroStemCell, and Kyoto University,s Institute ... Research report: Trends and Perspectives on the Evolving International ... comprehensive analysis of the growth and development of the ... research landscape for embryonic stem (ES) cell, human embryonic ...
Cached Biology News:CU-Boulder-led team finds first evidence of primates regularly sleeping in caves 2CU-Boulder-led team finds first evidence of primates regularly sleeping in caves 3CU-Boulder-led team finds first evidence of primates regularly sleeping in caves 4An important discovery related to anxiety disorders and trauma 2An important discovery related to anxiety disorders and trauma 3New report on stem cell research reveals the field is growing twice as fast as the world average 2New report on stem cell research reveals the field is growing twice as fast as the world average 3
... Western Protein Array was developed using a ... Arrays are manufactured using high quality denatured ... protein sample from each of 30 tissues ... molecular weight marker on a large size ...
... Microarrays Using the New FAST(tm) Frame Multi-Slide ... is designed to hold four, 16-pad FAST ... in a microplate footprint for high throughput ... the standards recommended by the Society of ...
... 2D Multi-User Applications Package Superior Protein ... Range: The ProXPRESS 2D Proteomic Imaging System ... both proteomic and general life science research ... the use of all dyes in the ...
fully automated system for the processing of microarrays on microscope slides...
Biology Products: